TNFRSF17-eiwit (C-His, mens)

TNFRSF17

BCM, BCMA, CD269, TNFRSF13A

C-His

< 1.0 EU per μg protein as determined by the LAL method.

1.Flow cytometric analysis of anti-BCMA CAR expression. 5e5 of anti-BCMA CAR-293 cells were stained with 100 μL of 0.5 μg/mL of AF 647-conjugated human BCMA Protein (Site-specific AF 647-conjugated, ECD, His Tag, Cat. No. 10620-H86H-SG) and negative control protein. Non-transduced 293 cells were used as a control (left) . AF 647 signal was used to evaluate the binding activity (QC tested) . 2.Binding activity of AF 647-conjugated BCMA protein to PBMC cells. PBMC cells were stained with FITC conjugated anti-CD3 antibody and AF 647-conjugated human BCMA Protein (Site-specific AF 647-conjugated, ECD, His Tag, Cat. No. 10620-H86H-SG) and detected by flow cytometry. FITC signal was used to evaluate the content of CD3+ T cells in PBMCs. AF 647 signal was used to evaluate the non-specific binding activity to PBMCs (QC tested) .

Met1-Ala54

The protein has a predicted molecular mass of 11.8 kDa.

Human